Our researcher David Rejeski (Global Fellow, Wilson Center) has published a white paper on Synthetic Biology in the United States, A Brief History of an Emerging Innovation System.
The paper captures the developments of the Synthetic Biology in the US during 1996 to 2016. The study is based on the latest data on VC investments, and firm starts.
A key message conveyed in this paper is that much of the emergence of the Synthetic Biology ecosystem happened without top down planning, technology road mapping, and heavy investments. This represents policy making in a dynamic emergent system with a high degree of digitalization and openness. These insights may provide a model for Science & Technology policy moving forward.